Activation of IL-6/STAT3, a classic signaling pathway in tumor cells, begins when IL-6 binds to IL-6Rα and gp130 receptor subunits on the membrane surface to form a complex that triggers phosphorylation of JAK kinase and ultimately activation of STAT3 (Hirano, 2021). The gene discussed is STAT3; the disease is neoplasm.